Gossamer Bio, Inc.
GOSS· Nasdaq
GOSSGossamer Bio, Inc.
Filed May 9, 2023 · 10-Q · 39 days after period end · 0001728117-23-000049
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Net Income | -$49.17M | -$57.79M | -$57.64M | -$54.07M |
| EPS Diluted | -$0.52 | -$0.76 | -$0.78 | -$0.87 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Gossamer Bio, Inc. · CIK 1728117 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 9, 2023 · 39 d after period end
